- 2017
-
Press releases - 18.10.2017
A Novel Animal Model to Speed Up the Fight Against Alzheimer’s Disease
For the first time, an animal model can express the two biological characteristics of Alzheimer’s disease. Researchers from CEA, Inserm, Paris-Sud and Paris-Descartes Universities, and CNRS have developed an animal model that reproduces the progression of the human disease. These results offer new possibilities for testing drugs and developing a diagnostic method involving a simple blood test. Their findings were published in Cerebral Cortex on October 18, 2017.
-
Press releases - 12.10.2017
BioPrint: Inserm Launches its Second Accelerator of Technological Research
La création d’Accélérateurs de Recherche Technologique est une priorité du plan d’orientation stratégique de l’Inserm. Ce 12 octobre 2017, l’Inserm inaugure son deuxième ART consacré à la “Bioimpression 3D” à Bordeaux. Il s’agit de la seule unité technologique utilisant les trois principales technologies de l’impression biologique en 3D, à savoir : le laser, le jet d’encre, et la micro-extrusion. Au sein de l’ART se côtoieront chercheurs et ingénieurs, afin de transformer le plus rapidement possible les avancées de la recherche en innovation technologique.
-
Press releases - 11.10.2017
First clinical proof of concept for functional ultrasound imaging of brain activity in newborns
Physicians from Inserm Unit 979 “Wave Physics for Medicine” at the ESPCI Paris together with clinician researchers from the neonatal intensive care unit of Robert-Debré AP-HP pediatric hospital and Inserm Unit 1141 have just made a scientific and medical breakthrough: the non-invasive imaging of brain activity in newborns using ultrasound. This will open up new avenues for bedside neurological diagnosis in full-term and premature babies. The details of their research have been published in the October 11, 2017 issue of Science Translational Medicine.
-
Press releases - 11.10.2017
Identification of a molecular mechanism associated with schizophrenia and bipolar disorder
A research team in psychiatry at CEA-Neurospin, together with the Mondor Institute of Biomedical Research (INSERM) and the Henri-Mondor (AP-HP) university hospitals, has shown that a genetic variant associated with several psychiatric conditions alters a prefrontal-limbic network, which may increase the risk of developing schizophrenia or bipolar disorder. The results of this study were published online on October 2, 2017 in Journal of Neuroscience.
-
Press releases - 11.10.2017
Maternal and neonatal health : preliminary results of the French National Perinatal Survey 2016
The French National Institute for Health and Medical Research (Inserm) and the Directorate of Research, Studies, Evaluation and Statistics (DREES) have published the preliminary results of the French National Perinatal Survey 2016. This report, based on a sample of births representing all births in France for the year 2016, presents the changes in the main perinatal indicators of health, medical practices and risk factors. It also describes the organization of healthcare in the country’s 517 maternity units.
-
Press releases - 10.10.2017
Biomedical Research Mobilized Around Thomas Pesquet
Space is an extraordinary laboratory for medicine and medical research on Earth. That is why Inserm and the CNES have been working together for more than a year[1] to accelerate research progress to improve the health of all of us. The presence of Thomas Pesquet, French astronaut from the European Space Agency (ESA), on board the International Space Station (ISS) for 6 months gave rise to many experiments, the preliminary results of which support the researchers’ hypotheses and sometimes even surprise them.
-
Press releases - 06.10.2017
Tuesday, October 10, 2017, is National “Dys” Day (dyslexia, dysphasia, dysorthographia, etc.)
The 11th edition of National “Dys” Day will be held on Tuesday, October 10, 2017. Created by the Fédération Française des DYS, it mobilizes parents who are members of associations together with professionals from across France. The various learning disabilities that begin with “dys”, and which are now better understood by the general public, affect around 6 million people in France [1](METTRE CHIFFRE). An event is held in Paris each year, attended by around 10,000 people. This year, it will take place on Saturday, October 14, 2017, from 9 a.m. to 6 p.m., at Université Paris 8.
-
Press releases - 06.10.2017
Colon cancer: APC protein affects immunity by preventing pre-cancerous inflammation
Adenomatous polyposis coli (APC) is a gene whose mutations are associated with a rare, hereditary form of colorectal cancer known as familial adenomatous polyposis. Research led by scientists at the Institut Pasteur and Inserm have recently demonstrated that mutations to this gene do not only lead to the emergence of colon polyps; they also harm the immune system, leaving it unable to tackle inflammation of the colonic mucosa. This dual impact supports the development of cancer. The finding, published in the journal Cell Reports on October 3rd, 2017, advances scientific knowledge on the development mechanisms of colorectal cancer.
-
What's on? - 06.10.2017
Tuesday, October 10, 2017, is National “Dys” Day (dyslexia, dysphasia, dysorthographia, etc.)
The 11th edition of National “Dys” Day will be held on Tuesday, October 10, 2017. Created by the Fédération Française des DYS, it mobilizes parents who are members of associations together with professionals from across France. The various learning disabilities that begin with “dys”, and which are now better understood by the general public, affect […]
-
News in brief - 03.10.2017
Benefits of Unit-Dose Antibiotic Sale
Between November 2014 and November 2015, a study conducted by Inserm (Unit 912 SESSTIM – Economic and Social Sciences, Health Systems and Medical Informatics), Université Aix-Marseille, IRD, CNRS and the PACA Regional Health Observatory, trialed the unit-dose dispensing of certain antibiotics across four regions in France. Out of 100 volunteer pharmacies, 75 pharmacies were randomly […]